About
GemCyclo Bio is an early-stage bio-pharmaceutical company holding a library of novel orally available cyclic peptides targeting validated molecular pathways of immune and inflammatory diseases (I&I), Cancer, and metabolic diseases.
The innovative new drugs are licensed from the Hebrew University of Jerusalem and designed and synthesized by Prof Chaim Gilon and his colleagues with the proprietary Cycloscan technology, rapidly achieving orally available small cyclic peptides which are highly potent and metabolically stable, enabling multiple routes of administration.
The novel GemCyclo Bio cyclic peptides embrace the best of small molecules and of larger protein drugs; they are easy to synthesize and of low immunogenicity as small molecules, and of highest affinity and selectivity to target active site as monoclonal antibodies (mAbs), and low off-target toxicity, all at the same time in one novel cyclic peptide molecule.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was GemCyclo Bio founded?
- GemCyclo Bio was founded in March 2025.
- What is GemCyclo Bio's primary focus?
- GemCyclo Bio is an early-stage bio-pharmaceutical company focused on developing novel orally available cyclic peptides for immune and inflammatory diseases, cancer, and metabolic diseases.
- Where is GemCyclo Bio headquartered?
- GemCyclo Bio is headquartered in Jerusalem, Israel.
- From which institution did GemCyclo Bio license its innovative new drugs?
- GemCyclo Bio licensed its innovative new drugs from the Hebrew University of Jerusalem.
- Who designed and synthesized GemCyclo Bio's novel drugs?
- Prof. Chaim Gilon and his colleagues designed and synthesized GemCyclo Bio's novel drugs using the proprietary Cycloscan technology.
- What is the current employee count for GemCyclo Bio?
- GemCyclo Bio currently has 5 employees.
- What is GemCyclo Bio's current funding stage?
- GemCyclo Bio is currently in the Pre-Funding stage.
- What is the total amount of funding GemCyclo Bio has raised to date?
- GemCyclo Bio has not yet raised any funding, with a total raised amount of $0 USD.
- Who are the co-founders of GemCyclo Bio?
- The co-founders of GemCyclo Bio are Doron Friedman and Oron Yacoby-Zeevi.